Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anatomy of the Heart01:27

Anatomy of the Heart

120.0K
The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
120.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Half-Cut Balloon, a Novel, Ultra-Rapid, and Cheap Technique to Seal a Coronary Perforation.

JACC. Cardiovascular interventions·2020
Same author

Study of C-reactive protein and myocardial infarction in the Indian population.

Indian journal of clinical biochemistry : IJCB·2013
Same author

Genes of renin angiotensin system and coronary heart disease.

Indian journal of clinical biochemistry : IJCB·2012
Same author

Comparative analysis of RBC membrane lipids in thalassemia, and iron deficiency anemia in relation to hypochromia and oxidant injury.

Indian journal of clinical biochemistry : IJCB·2012
Same author

Circulating thrombotic and haemostatic components in patients with coronary artery disease.

Indian journal of clinical biochemistry : IJCB·2012
Same author

Matrix metalloproteinase-3 (MMP-3) -1612 5A/6A promoter polymorphism in coronary artery disease in Indian population.

Indian journal of clinical biochemistry : IJCB·2012
Same journal

Letter to the Editor on "Clinical profile and optical coherence tomography based morphological characteristics of coronary in-stent restenosis: A cross-sectional study".

Indian heart journal·2026
Same journal

Evolving spectrum and outcomes of infective endocarditis in North India: A comparative analysis between people who inject drugs and those who do not.

Indian heart journal·2026
Same journal

Medical management of hypertrophic cardiomyopathy.

Indian heart journal·2026
Same journal

Response to the Letter to the Editor, "Reappraising the role of CMRI in HFpEF: A tiny step in the black and white world of HFpEF".

Indian heart journal·2026
Same journal

Indian society of electrocardiology position statement on improving CPR awareness in the Indian public.

Indian heart journal·2026
Same journal

Intracoronary thrombus in ST-segment elevation myocardial infarction: Practical management strategies for the interventional cardiologist.

Indian heart journal·2026
See all related articles

Related Experiment Video

Updated: Feb 8, 2026

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

846

Reperfusing the myocardium - a damocles Sword.

V K Shah1, K K Shalia2

  • 1Sir H.N. Reliance Foundation Hospital and Research Centre, Cardiology Dept. Mumbai 400 004, India.

Indian Heart Journal
|July 3, 2018
PubMed
Summary
This summary is machine-generated.

Reperfusion injury (RI) causes significant myocardial damage after blood flow is restored to ischemic heart tissue. Current treatments are ineffective, necessitating novel therapeutic strategies to prevent this lethal reperfusion injury.

Keywords:
Aspiration thrombectomyIschemic conditioningMicrovascular obstructionMyocardial stunningNo-reflowPharmacological conditioning

More Related Videos

Confirmation of Myocardial Ischemia and Reperfusion Injury in Mice Using Surface Pad Electrocardiography
09:23

Confirmation of Myocardial Ischemia and Reperfusion Injury in Mice Using Surface Pad Electrocardiography

Published on: November 24, 2016

13.9K
Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

8.5K

Related Experiment Videos

Last Updated: Feb 8, 2026

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
09:53

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

846
Confirmation of Myocardial Ischemia and Reperfusion Injury in Mice Using Surface Pad Electrocardiography
09:23

Confirmation of Myocardial Ischemia and Reperfusion Injury in Mice Using Surface Pad Electrocardiography

Published on: November 24, 2016

13.9K
Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

8.5K

Area of Science:

  • Cardiology
  • Pathophysiology
  • Biomedical Research

Background:

  • Periodic ischemia can lead to myocardial injury upon reperfusion, known as lethal reperfusion injury (RI).
  • Experimental data indicates that reperfusion contributes significantly to tissue death, alongside ischemia.
  • This injury manifests as dysfunction in the myocardium, vasculature, or electrophysiology following blood flow restoration.

Purpose of the Study:

  • To highlight the challenges and limitations of current therapeutic modalities for managing ischemic myocardium.
  • To underscore the inadequacy of existing clinical trials in preventing reperfusion injury.
  • To emphasize the need for exploring novel approaches to combat lethal reperfusion injury.

Main Methods:

  • Review of experimental studies on myocardial injury following ischemia and reperfusion.
  • Analysis of the pathophysiology of reperfusion injury.
  • Evaluation of the outcomes of clinical trials for preventing reperfusion injury.

Main Results:

  • Reperfusion injury accounts for substantial myocardial damage, often equivalent to ischemic damage.
  • Existing treatments are inefficient in mitigating the effects of reperfusion injury.
  • Despite progress in understanding RI, clinical prevention strategies have largely failed.

Conclusions:

  • Reperfusion injury remains a critical clinical problem with limited effective interventions.
  • Current understanding and preclinical successes have not translated into successful clinical prevention of RI.
  • There is an urgent need for innovative therapeutic strategies to address lethal reperfusion injury.